FCGR3B and lobular neoplasia: However, no significant differences were observed in FCGR2B-I232T (Figure 1C,D and Table A1) nor FCGR3B-NA1/NA2 (Figure 1G,H and Table A1) between patients with LN and controls or patients with LWN.